学术探索
学术期刊
新闻热点
数据分析
智能评审

Arthritis medicines and cardiovascular events - "House of coxibs"

被引：80
作者：
Topol, EJ
机构：
[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
[2] Cleveland Clin, Lerner Coll Med, Off Provost, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2005年 / 293卷 / 03期
关键词：
D O I：
10.1001/jama.293.3.366
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：366 / 368
页数：3
相关论文
共 21 条
  • [11] Risk of cardiovascular events associated with selective COX-2 inhibitors
    Mukherjee, D
    Nissen, SE
    Topol, EJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (08): : 954 - 959
  • [12] Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery
    Ott, E
    Nussmeier, NA
    Duke, PC
    Feneck, RO
    Alston, RP
    Snabes, MC
    Hubbard, RC
    Hsu, PH
    Saidman, LJ
    Mangano, DT
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (06) : 1481 - 1492
  • [13] Cardiovascular toxicity of valdecoxib
    Ray, WA
    Griffin, MR
    Stein, CM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (26) : 2767 - 2767
  • [14] Non-steroidal anti-inflamatory drugs and risk of serious coronary heart disease: an observational cohort study
    Ray, WA
    Stein, CM
    Hall, K
    Daugherty, JR
    Griffin, MR
    [J]. LANCET, 2002, 359 (9301) : 118 - 123
  • [15] Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
    Silverstein, FE
    Faich, G
    Goldstein, JL
    Simon, LS
    Pincus, T
    Whelton, A
    Makuch, R
    Eisen, G
    Agarwal, NM
    Stenson, WF
    Burr, AM
    Zhao, WW
    Kent, JD
    Lefkowith, JB
    Verburg, KM
    Geis, GS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (10): : 1247 - 1255
  • [16] Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults
    Solomon, DH
    Schneeweiss, S
    Glynn, RJ
    Kiyota, Y
    Levin, R
    Mogun, H
    Avorn, J
    [J]. CIRCULATION, 2004, 109 (17) : 2068 - 2073
  • [17] A coxib a day won't keep the doctor away
    Topol, EJ
    Falk, GW
    [J]. LANCET, 2004, 364 (9435) : 639 - 640
  • [18] Failing the public health - Rofecoxib, Merck, and the FDA
    Topol, EJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (17) : 1707 - 1709
  • [19] TOPOL EJ, IN PRESS N ENGL J ME
  • [20] *US FDA, 2004, BEXTR LAB UPD BOX WA
123